What to do: Do not consume recalled products to which you are allergic or sensitive. Do not consume the recalled products if you have celiac disease or other gluten-related disorders.
Audience: General public
Recall class: Class 1
Affected products
Brand
Product
Size
UPC
Codes
Undeclared Allergen
Apetito HFS
Meatballs in Gravy
329 g
None
23 DE 22
Egg, Wheat
Apetito HFS
Meatballs and Peppers
337 g
None
23 DE 12
23 DE 20
Egg, Wheat
Heart to Home Meals
Honey Garlic Meatballs
318 g
None
23 NO 29
24 JA 09
Egg, Milk
Heart to Home Meals
Spaghetti and Meatballs
356 g
None
23 DE 19
Egg, Milk
Heart to Home Meals
Sweet and Sour Meatballs
305 g
None
23 NO 29
Egg, Milk
Heart to Home Meals
Meatballs in Mushroom Sauce
364 g
None
23 DE 01
24 JA 10
Egg, Milk, Wheat
Issue
The affected products are being recalled from the marketplace because they contain egg, milk, and wheat which are not declared on the label.
The recalled products have been sold in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, and Nova Scotia.
What you should do
Check to see if you have recalled products
Do not consume recalled products to which you are allergic or sensitive as they may cause a serious or life-threatening reaction
If you have celiac disease or other gluten-related disorders, do not consume the recalled products as they may cause a serious or life-threatening reaction
Do not serve, use, sell or distribute recalled products
Recalled products should be thrown out or returned to the location where they were purchased
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...
YOUR LEGAL RIGHTS MAY BE AFFECTED
There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...